Neurocrine Biosciences, Inc. logo NBIX - Neurocrine Biosciences, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 32
HOLD 5
SELL 0
STRONG
SELL 0
| PRICE TARGET: $184.38 DETAILS
HIGH: $230.00
LOW: $140.00
MEDIAN: $185.00
CONSENSUS: $184.38
UPSIDE: 17.66%

Profitability Ratios

Ratio Value
GP Margin 98.2%
EBIT Margin 22.3%
EBITDA Margin 23.3%
Operating Margin 21.6%
Pretax Margin 24.7%
Cont. Ops Margin 16.7%
Net Margin 16.7%
Bottom Line Margin 16.7%

Liquidity Ratios

Ratio Value
Current Ratio 3.39
Quick Ratio 3.30
Solvency Ratio 0.369
Cash Ratio 0.96

Valuation Ratios

Ratio Value
Price/Earnings
29.49
Hist. avg: 52.2
Peers avg: 24.2
PEG Ratio 0.71
Forward PEG 0.71
Price/Book 4.34
Price/Sales 4.93
Price/FCF 18.85
Price/Op Cash Flow 18.03

Debt Ratios

Ratio Value
Debt/Assets 0.0897
Debt/Equity 0.1277
Debt/Capital 0.1132
Long-Term Debt/Capital 0.0000
Financial Leverage 1.42

Cash Flow Ratios

Ratio Value
Working Capital Turnover 1.91
Operating Cash Flow Ratio 1.053
Operating Cash Flow/Sales 27.4%
Free Cash Flow/Operating Cash Flow 95.7%

Coverage Ratios

Ratio Value
Debt Service Coverage 0.00
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage 0.00
Operating Cash Flow Coverage 1.88
Capital Expenditure Coverage 23.02
Dividend + Capital Expenditure Coverage 23.02

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 28.75
EPS 4.810
Debt/Share 4.1739
Cash/Share 14.88
Book Value/Share 32.69
Tangible BV/Share 32.69
Equity/Share 32.69
Operating Cash Flow/Share 7.866
Capital Expenditure/Share 0.342
FCF/Share 7.525

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.678
Earnings Before Tax/EBIT 1.139
Price/Fair Value 4.34
Debt/Market Cap 0.0000
Effective Tax Rate 32.2%
Enterprise Value Multiple 20.72